NO942606D0 - Use of phenalkylamines - Google Patents
Use of phenalkylaminesInfo
- Publication number
- NO942606D0 NO942606D0 NO942606A NO942606A NO942606D0 NO 942606 D0 NO942606 D0 NO 942606D0 NO 942606 A NO942606 A NO 942606A NO 942606 A NO942606 A NO 942606A NO 942606 D0 NO942606 D0 NO 942606D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halogen
- formula
- atom
- image
- Prior art date
Links
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Use of compounds of the formula <IMAGE> in which one of R<1> and R<2> is C1-7-alkyl and the other is C1-7-alkyl or C2-6-alkenylmethyl, L is C1-11-alkylene or C2-11-alkenylene which is optionally bonded via an O atom to the phenyl group, or L is 1,4-phenylene, n is 0 or, if L contains an O atom, n is 0 or 1, Q is C1-7-alkyl, C2-10-alkenyl or a group of the formula Q': <IMAGE> R is H, halogen, CF3, CN or NO2, R<3> and R<4> are H, C1-4-alkyl or halogen, and R<5> is H or, if R is H, H or halogen, and their pharmaceutically acceptable acid addition salts for producing cholesterol-lowering medicinal agents, and compounds covered by formula I.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH210793 | 1993-07-14 | ||
| CH132094 | 1994-04-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO942606D0 true NO942606D0 (en) | 1994-07-12 |
| NO942606L NO942606L (en) | 1995-01-16 |
| NO309924B1 NO309924B1 (en) | 2001-04-23 |
Family
ID=25687322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942606A NO309924B1 (en) | 1993-07-14 | 1994-07-12 | Use of phenalkylamines and new phenylalkylamines |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US5495048A (en) |
| EP (1) | EP0636367B1 (en) |
| JP (1) | JP2519022B2 (en) |
| KR (1) | KR100312441B1 (en) |
| CN (1) | CN1087934C (en) |
| AT (1) | ATE191142T1 (en) |
| AU (1) | AU684507B2 (en) |
| CA (1) | CA2126518C (en) |
| CZ (1) | CZ288518B6 (en) |
| DE (1) | DE59409248D1 (en) |
| DK (1) | DK0636367T3 (en) |
| ES (1) | ES2144471T3 (en) |
| GR (1) | GR3033645T3 (en) |
| HU (1) | HUT70835A (en) |
| IL (1) | IL110254A (en) |
| NO (1) | NO309924B1 (en) |
| NZ (1) | NZ260968A (en) |
| PH (1) | PH31092A (en) |
| PT (1) | PT636367E (en) |
| RU (1) | RU2141942C1 (en) |
| TW (1) | TW438774B (en) |
| UA (1) | UA37199C2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
| CA2190699A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Tertiary amines |
| AU2001289642B2 (en) * | 2000-07-18 | 2005-01-13 | F. Hoffmann-La Roche Ag | Aniline derivatives |
| AU2001293744B2 (en) | 2000-08-16 | 2007-05-10 | F. Hoffmann-La Roche Ag | Novel aminocyclohexane derivatives |
| US6964974B2 (en) | 2000-09-08 | 2005-11-15 | Hoffmann-La Roche Inc. | 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| US6503907B2 (en) * | 2000-11-28 | 2003-01-07 | Hoffmann-La Roche Inc. | Indole and dihydroindole derivatives |
| US6706751B2 (en) | 2000-12-21 | 2004-03-16 | Hoffman-La Roche Inc. | Dihydroindole and tetrahydroquinoline derivatives |
| PL371471A1 (en) * | 2001-12-12 | 2005-06-13 | F.Hoffmann-La Roche Ag | Substituted cyclohexane derivatives |
| US7012077B2 (en) * | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
| US6727277B1 (en) | 2002-11-12 | 2004-04-27 | Kansas State University Research Foundation | Compounds affecting cholesterol absorption |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| AU2004274155A1 (en) * | 2003-09-22 | 2005-03-31 | F. Hoffmann-La Roche Ag | Aminoalkylamide substituted cyclohexyl derivatives |
| EP2084127A1 (en) * | 2006-11-13 | 2009-08-05 | Pfizer Products Inc. | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| CN108530390B (en) * | 2017-03-06 | 2020-04-21 | 西南化工研究设计院有限公司 | A kind of alkylation method of 4-hydroxybenzophenone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647863A (en) * | 1968-11-25 | 1972-03-07 | Richardson Merrell Inc | Aminoalkoxy-triphenyl ethylenes and the salts thereof |
| US3928449A (en) * | 1969-04-03 | 1975-12-23 | Sandoz Ag | Aminoalkoxy-terphenyls and the salts thereof |
| CA2016738A1 (en) * | 1989-06-08 | 1990-12-08 | Philippe Guerry | Substituted aminoalkylbenzene derivatives |
| US5214046A (en) * | 1989-07-27 | 1993-05-25 | Hoffmann-La Roche Inc. | Substituted aminoalkoxybenzene anti-fungicidal compositions and use |
| CA2020888A1 (en) * | 1989-07-27 | 1991-01-28 | Philippe Guerry | Substituted aminoalkoxybenzene derivatives |
| CA2044533A1 (en) * | 1990-06-29 | 1991-12-30 | Philippe Guerry | Substituted aminoalkylbiphenyl derivatives |
| US5239084A (en) * | 1990-06-29 | 1993-08-24 | Hoffmann-La Roche Inc. | Substituted aminoalkyl biphenyl compounds |
-
1994
- 1994-06-16 TW TW083105454A patent/TW438774B/en not_active IP Right Cessation
- 1994-06-17 US US08/261,615 patent/US5495048A/en not_active Expired - Fee Related
- 1994-06-22 CA CA002126518A patent/CA2126518C/en not_active Expired - Fee Related
- 1994-07-01 DE DE59409248T patent/DE59409248D1/en not_active Expired - Fee Related
- 1994-07-01 DK DK94110246T patent/DK0636367T3/en active
- 1994-07-01 PT PT94110246T patent/PT636367E/en unknown
- 1994-07-01 ES ES94110246T patent/ES2144471T3/en not_active Expired - Lifetime
- 1994-07-01 AT AT94110246T patent/ATE191142T1/en not_active IP Right Cessation
- 1994-07-01 EP EP94110246A patent/EP0636367B1/en not_active Expired - Lifetime
- 1994-07-08 AU AU67358/94A patent/AU684507B2/en not_active Ceased
- 1994-07-08 JP JP6157038A patent/JP2519022B2/en not_active Expired - Fee Related
- 1994-07-08 RU RU94026094/04A patent/RU2141942C1/en not_active IP Right Cessation
- 1994-07-08 NZ NZ260968A patent/NZ260968A/en unknown
- 1994-07-08 IL IL110254A patent/IL110254A/en not_active IP Right Cessation
- 1994-07-12 PH PH48609A patent/PH31092A/en unknown
- 1994-07-12 CZ CZ19941676A patent/CZ288518B6/en not_active IP Right Cessation
- 1994-07-12 NO NO942606A patent/NO309924B1/en unknown
- 1994-07-13 UA UA94075630A patent/UA37199C2/en unknown
- 1994-07-13 CN CN94108447A patent/CN1087934C/en not_active Expired - Fee Related
- 1994-07-13 HU HU9402085A patent/HUT70835A/en unknown
- 1994-07-13 KR KR1019940016823A patent/KR100312441B1/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/468,114 patent/US5574071A/en not_active Expired - Fee Related
- 1995-11-08 US US08/555,054 patent/US5637771A/en not_active Expired - Fee Related
-
2000
- 2000-06-12 GR GR20000401332T patent/GR3033645T3/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1087934C (en) | 2002-07-24 |
| US5637771A (en) | 1997-06-10 |
| CZ167694A3 (en) | 1995-01-18 |
| ATE191142T1 (en) | 2000-04-15 |
| GR3033645T3 (en) | 2000-10-31 |
| HUT70835A (en) | 1995-11-28 |
| AU6735894A (en) | 1995-01-27 |
| TW438774B (en) | 2001-06-07 |
| AU684507B2 (en) | 1997-12-18 |
| DE59409248D1 (en) | 2000-05-04 |
| KR100312441B1 (en) | 2002-10-31 |
| IL110254A (en) | 1998-04-05 |
| HU9402085D0 (en) | 1994-09-28 |
| NZ260968A (en) | 1996-06-25 |
| NO942606L (en) | 1995-01-16 |
| PT636367E (en) | 2000-07-31 |
| US5495048A (en) | 1996-02-27 |
| NO309924B1 (en) | 2001-04-23 |
| ES2144471T3 (en) | 2000-06-16 |
| CN1103781A (en) | 1995-06-21 |
| RU94026094A (en) | 1996-05-20 |
| EP0636367A1 (en) | 1995-02-01 |
| US5574071A (en) | 1996-11-12 |
| IL110254A0 (en) | 1994-10-21 |
| CZ288518B6 (en) | 2001-07-11 |
| DK0636367T3 (en) | 2000-07-31 |
| KR960014096A (en) | 1996-05-22 |
| RU2141942C1 (en) | 1999-11-27 |
| UA37199C2 (en) | 2001-05-15 |
| EP0636367B1 (en) | 2000-03-29 |
| CA2126518A1 (en) | 1995-01-15 |
| JPH0753479A (en) | 1995-02-28 |
| CA2126518C (en) | 2006-11-21 |
| JP2519022B2 (en) | 1996-07-31 |
| PH31092A (en) | 1998-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9604786D0 (en) | New compounds | |
| NO942606L (en) | Use of phenalkylamines | |
| DK0565549T3 (en) | Use of 1,3-oxathiolannucleoside analogues for the preparation of a preparation for the treatment of hepatitis B | |
| FI955828A0 (en) | New peptide derivatives | |
| FI914928A0 (en) | HYDROXIMETHYL (METHYLENCYCLOPENTYL) PURINER OCH -PYRIMIDINER. | |
| ATE107499T1 (en) | HAIR STRENGTHENING AGENT. | |
| ATE179706T1 (en) | N-HETEROARYL-N'-PHENYLUREA DERIVATIVES, THEIR PREPARATION AND USE | |
| FI943142A0 (en) | Amide and urea derivatives with anti-high cholesterol activity, their preparation and therapeutic uses | |
| NO934536D0 (en) | Phenoxy and phenoxyalkylpepiridines as antivirals | |
| FI911286A0 (en) | CHEMICAL FOERENINGAR. | |
| ATE157088T1 (en) | NEW CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES | |
| NO943521L (en) | Use of a pyrrolidine acetamide derivative for the preparation of a therapeutic agent | |
| ES2160649T3 (en) | NEW DAIRY COMPOUNDS AND PROCEDURES FOR PREPARATION. | |
| DK132188D0 (en) | USE OF TETRAHYDROBENZ (C, D) INDOL-6 CARBOXAMIDES AS ANXIOLYTICS | |
| DE69525633D1 (en) | CHINOXALINE DERIVATIVES AND THEIR THERAPEUTIC USE | |
| ES2077473T3 (en) | NEW THIOCHROMANIC COMPOUNDS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| AU625238B2 (en) | Anti-psychotic piperidylbenzimidazole compounds | |
| DK0556813T3 (en) | Amphoteric tricyclic compounds such as antihistamine and antiallergic agents | |
| ATE192141T1 (en) | AROMATIC HYDROXAMIC ACID COMPOUNDS, THEIR PREPARATION AND USE | |
| NO940034D0 (en) | Nonatetraensyrederivat | |
| NO842003L (en) | SUBSTITUTED ISOQINOLINE DERIVATIVES | |
| DE69305330D1 (en) | Aminoalkylchomones, processes for their preparation and the pharmaceutical compositions containing them | |
| NO840732L (en) | ANALOGY PROCEDURE FOR PREPARING THE THERAPEUTIC ACTIVE COMPOUND N- (3-TRIFLUORMETHYLPHENYL) -N'-PROPARGYLPIPERAZINE | |
| DE69505756D1 (en) | Process for the preparation of (-) - N-methyl-N- [4- (4-phenyl-4-acetylaminopiperidin-1-yl) -2- (3,4-dichlorophenyl) butyl] benzamide and its pharmaceutically acceptable salt | |
| DE69320542D1 (en) | Pyrrolothienopyrazine compounds as 5HT3 receptor antagonists |